GE HealthCare Technologies Inc. (GEHC) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q1 FY2026, filed Apr 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the GEHC SEC filings page.
GE HealthCare Technologies Inc. (GEHC) reported $21.0B in revenue over the twelve months to Mar 31, 2026, up 6.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
GE HealthCare shows steady growth, but rising capital spending is weakening cash conversion even as leverage and liquidity improve.
The business recovered profitability without recovering cash yield: net margin rose from8.0% in FY2023 to10.1% in FY2025. Over the same span, free-cash-flow margin fell from8.8% to7.3% , indicating that more of the improved accounting profit was not converting into discretionary cash.
Capital expenditures rose from
Short-term liquidity strengthened: current ratio rose from 1.0x in FY2023 to 1.4x in FY2025, giving current assets more room relative to near-term obligations. Debt-to-equity fell from 1.2x to 0.9x, although long-term debt reached
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of GE HealthCare Technologies Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
GE HealthCare Technologies Inc. has an operating margin of 13.4%, meaning the company retains $13 of operating profit per $100 of revenue. This strong profitability earns a score of 80/100, reflecting efficient cost management and pricing power. This is up from 13.3% the prior year.
GE HealthCare Technologies Inc.'s revenue grew a modest 4.8% year-over-year to $20.6B. This slow but positive growth earns a score of 40/100.
GE HealthCare Technologies Inc. has a moderate D/E ratio of 0.91. This balance of debt and equity financing earns a leverage score of 38/100.
GE HealthCare Technologies Inc.'s current ratio of 1.37 indicates adequate short-term liquidity, earning a score of 37/100. The company can meet its near-term obligations, though with limited headroom.
GE HealthCare Technologies Inc. has a free cash flow margin of 7.3%, earning a moderate score of 58/100. The company generates positive cash flow after capital investments, but with room for improvement.
GE HealthCare Technologies Inc. earns a strong 20.1% return on equity (ROE), meaning it generates $20 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 76/100. This is down from 23.6% the prior year.
GE HealthCare Technologies Inc. scores 1.79, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
GE HealthCare Technologies Inc. passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, GE HealthCare Technologies Inc. generates $0.95 in operating cash flow ($2.0B OCF vs $2.1B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
GE HealthCare Technologies Inc. earns $6.28 in operating income for every $1 of interest expense ($2.8B vs $440.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
GE HealthCare Technologies Inc. generated $5.1B in revenue in Q1 2026. This represents an increase of 7.4% from the same quarter a year earlier. Against the prior quarter it is down 10.0%.
GE HealthCare Technologies Inc.'s EBITDA was $668.0M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 12.7% from the same quarter a year earlier. Against the prior quarter it is down 31.3%.
GE HealthCare Technologies Inc. reported $389.0M in net income in Q1 2026. This represents a decrease of 31.0% from the same quarter a year earlier. Against the prior quarter it is down 33.8%.
GE HealthCare Technologies Inc. earned $0.85 per diluted share (EPS) in Q1 2026. This represents a decrease of 30.9% from the same quarter a year earlier. Against the prior quarter it is down 34.1%.
Cash & Balance Sheet
GE HealthCare Technologies Inc. generated $112.0M in free cash flow in Q1 2026, representing cash available after capex. This represents an increase of 14.3% from the same quarter a year earlier. Against the prior quarter it is down 87.8%.
GE HealthCare Technologies Inc. held $2.3B in cash against $10.1B in long-term debt as of Q1 2026.
GE HealthCare Technologies Inc. paid $0.04 per share in dividends in Q1 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
GE HealthCare Technologies Inc.'s gross margin was 38.5% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is down 3.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.2 percentage points.
GE HealthCare Technologies Inc.'s operating margin was 10.0% in Q1 2026, reflecting core business profitability. This is down 3.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.5 percentage points.
GE HealthCare Technologies Inc.'s net profit margin was 7.6% in Q1 2026, showing the share of revenue converted to profit. This is down 4.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.7 percentage points.
GE HealthCare Technologies Inc.'s ROE was 3.6% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.0 percentage points.
Capital Allocation
GE HealthCare Technologies Inc. invested $345.0M in research and development in Q1 2026. This represents an increase of 0.3% from the same quarter a year earlier. Against the prior quarter it is up 7.1%.
GE HealthCare Technologies Inc. spent $100.0M on share buybacks in Q1 2026, returning capital to shareholders by reducing shares outstanding.
GE HealthCare Technologies Inc. invested $178.0M in capex in Q1 2026, funding long-term assets and infrastructure. This represents an increase of 17.1% from the same quarter a year earlier. Against the prior quarter it is up 32.8%.
GEHC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1B+7.4% | $5.7B+7.1% | $5.1B+5.8% | $5.0B+3.5% | $4.8B+2.7% | $5.3B+2.2% | $4.9B+0.9% | $4.8B+0.5% |
| Gross Profit | $2.0B-1.7% | $2.3B-0.6% | $2.0B-1.8% | $2.0B-0.8% | $2.0B+5.8% | $2.3B+5.5% | $2.0B+4.7% | $2.0B+3.2% |
| R&D Expenses | $345.0M+0.3% | $322.0M-6.4% | $292.0M-7.6% | $302.0M-7.6% | $344.0M+6.2% | $344.0M+9.2% | $316.0M-1.9% | $327.0M+9.7% |
| SG&A Expenses | $1.1B+7.4% | $1.1B-1.7% | $1.0B+1.1% | $1.0B-3.6% | $1.0B+0.2% | $1.1B-1.9% | $1.0B+3.8% | $1.1B-0.5% |
| Operating Income | $515.0M-18.1% | $827.0M+3.2% | $653.0M-3.4% | $654.0M+7.6% | $629.0M+16.5% | $801.0M+16.3% | $676.0M+9.6% | $608.0M+6.7% |
| EBITDA | $668.0M-12.7% | $973.0M+3.5% | $802.0M-2.1% | $801.0M+5.7% | $765.0M+11.2% | $940.0M+12.8% | $819.0M+6.4% | $758.0M+4.4% |
| Interest Expense | $96.0M-12.7% | $106.0M-12.4% | $111.0M-14.6% | $113.0M-13.7% | $110.0M-9.8% | $121.0M-7.6% | $130.0M-5.8% | $131.0M-4.4% |
| Income Tax | $94.0M-9.6% | $218.0M+127.1% | $179.0M+6.5% | $113.0M-21.0% | $104.0M-16.1% | $96.0M-50.3% | $168.0M-32.8% | $143.0M+4.4% |
| Net Income | $389.0M-31.0% | $588.0M-18.4% | $446.0M-5.1% | $486.0M+13.6% | $564.0M+50.8% | $721.0M+78.9% | $470.0M+25.3% | $428.0M+2.4% |
| EPS (Basic) | $0.85-30.9% | $1.29-18.4% | $0.98-4.9% | $1.06+12.8% | $1.23+50.0% | $1.58+77.5% | $1.03+25.6% | $0.94+2.2% |
| EPS (Diluted) | $0.85-30.9% | $1.29-17.8% | $0.98-3.9% | $1.06+14.0% | $1.23+51.9% | $1.57+78.4% | $1.02+24.4% | $0.93+2.2% |
| Diluted Shares (Avg) | 457M-0.4% | N/A | 457M-0.4% | 458M-0.2% | 459M0.0% | N/A | 459M+0.2% | 459M+0.2% |
Not reported in any period shown, so not listed: Cost of Revenue.
GEHC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $37.1B+10.5% | $36.9B+11.5% | $36.1B+6.7% | $35.5B+11.5% | $33.6B+4.3% | $33.1B+2.0% | $33.9B+4.5% | $31.9B-1.4% |
| Current Assets | $10.4B+7.1% | $12.5B+26.3% | $11.9B+11.8% | $11.3B+28.4% | $9.7B+3.9% | $9.9B+5.2% | $10.6B+12.4% | $8.8B-4.7% |
| Cash & Equivalents | $2.3B-7.9% | $4.5B+56.3% | $4.0B+12.8% | $3.7B+87.1% | $2.5B-3.8% | $2.9B+15.2% | $3.5B+47.4% | $2.0B+3.2% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $2.4B+9.0% | $2.2B+15.2% | $2.3B+8.5% | $2.3B+12.9% | $2.2B+8.5% | $1.9B-1.1% | $2.1B-0.2% | $2.0B-10.6% |
| Long-Term Investments | $352.0M+49.8% | $351.0M-5.9% | $302.0M-16.3% | $244.0M-28.2% | $235.0M-32.1% | $373.0M+4.5% | $361.0M | $340.0M |
| Goodwill | $15.1B+12.6% | $13.5B+2.7% | $13.4B+2.3% | $13.4B+2.3% | $13.4B+3.5% | $13.1B+1.5% | $13.1B+1.7% | $13.1B+1.4% |
| Total Liabilities | $26.2B+8.5% | $26.3B+7.7% | $25.9B+2.2% | $25.5B+7.1% | $24.2B-1.8% | $24.4B-2.8% | $25.3B+1.1% | $23.9B-4.5% |
| Current Liabilities | $8.5B-14.4% | $9.1B-4.7% | $10.1B+16.2% | $9.7B+17.2% | $10.0B+12.5% | $9.6B+6.4% | $8.7B+14.6% | $8.3B+9.7% |
| Non-Current Liabilities | $17.7B+24.6% | $17.2B+15.6% | $15.8B-5.0% | $15.8B+1.7% | $14.2B-9.8% | $14.9B-7.9% | $16.7B-4.8% | $15.5B-10.7% |
| Long-Term Debt | $10.1B+49.9% | $9.5B+27.5% | $8.3B-11.1% | $8.3B+0.4% | $6.8B-18.1% | $7.4B-11.7% | $9.3B-9.2% | $8.2B-19.5% |
| Total Equity | $10.7B+16.1% | $10.4B+22.9% | $10.0B+20.2% | $9.7B+24.5% | $9.2B+24.0% | $8.4B+18.4% | $8.3B+16.6% | $7.8B+9.8% |
| Retained Earnings | $5.7B+48.4% | $5.3B+61.9% | $4.7B+84.1% | $4.3B+104.4% | $3.8B+125.8% | $3.3B+146.0% | $2.6B+173.0% | $2.1B+264.8% |
Not reported in any period shown, so not listed: Accounts Receivable.
GEHC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $290.0M+16.0% | $1.1B+15.0% | $593.0M-20.1% | $94.0M+179.0% | $250.0M-40.3% | $913.0M-13.0% | $742.0M+14.2% | -$119.0M-77.6% |
| Depreciation & Amortization | $153.0M+12.5% | $146.0M+4.3% | $149.0M+4.2% | $147.0M-2.0% | $136.0M-8.1% | $140.0M-2.8% | $143.0M-6.5% | $150.0M-3.8% |
| Stock-Based Compensation | $35.0M+59.1% | N/A | N/A | N/A | $22.0M-35.3% | N/A | N/A | N/A |
| Capital Expenditures | $178.0M+17.1% | $134.0M+31.4% | $110.0M+22.2% | $86.0M+34.4% | $152.0M+4.8% | $102.0M+8.5% | $90.0M+12.5% | $64.0M-8.6% |
| Free Cash Flow | $112.0M+14.3% | $916.0M+12.9% | $483.0M-25.9% | $8.0M+104.4% | $98.0M-64.2% | $811.0M-15.2% | $652.0M+14.4% | -$183.0M-33.6% |
| Investing Cash Flow | -$2.5B-514.3% | -$269.0M-12.1% | -$148.0M-8.0% | -$223.0M+36.1% | -$407.0M-116.5% | -$240.0M-172.7% | -$137.0M-14.2% | -$349.0M-315.5% |
| Financing Cash Flow | $21.0M+107.3% | -$293.0M+77.1% | -$165.0M-118.1% | $1.4B+2487.7% | -$286.0M-86.9% | -$1.3B-41.9% | $914.0M+3908.3% | -$57.0M+74.9% |
| Dividends Paid | $16.0M0.0% | $16.0M+14.3% | $32.0M+128.6% | $16.0M+14.3% | $16.0M+14.3% | $14.0M+7.7% | $14.0M0.0% | $14.0M-48.1% |
| Share Buybacks | $100.0M | $0 | $100.0M | $100.0M | $0 | $0 | $0 | N/A |
GEHC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.5%-3.6pp | 39.7%-3.1pp | 38.7%-3.0pp | 39.6%-1.7pp | 42.1%+1.2pp | 42.8%+1.3pp | 41.7%+1.5pp | 41.4%+1.1pp |
| Operating Margin | 10.0%-3.1pp | 14.5%-0.6pp | 12.7%-1.2pp | 13.1%+0.5pp | 13.2%+1.6pp | 15.1%+1.8pp | 13.9%+1.1pp | 12.6%+0.7pp |
| Net Margin | 7.6%-4.2pp | 10.3%-3.2pp | 8.7%-1.0pp | 9.7%+0.9pp | 11.8%+3.8pp | 13.6%+5.8pp | 9.7%+1.9pp | 8.8%+0.2pp |
| Return on Equity | 3.6%-2.5pp | 5.7%-2.9pp | 4.5%-1.2pp | 5.0%-0.5pp | 6.1%+1.1pp | 8.5%+2.9pp | 5.7%+0.4pp | 5.5%-0.4pp |
| Return on Assets | 1.1%-0.6pp | 1.6%-0.6pp | 1.2%-0.2pp | 1.4%0.0pp | 1.7%+0.5pp | 2.2%+0.9pp | 1.4%+0.2pp | 1.3%+0.1pp |
| Current Ratio | 1.22+0.2x | 1.37+0.3x | 1.180.0x | 1.16+0.1x | 0.98-0.1x | 1.040.0x | 1.230.0x | 1.06-0.2x |
| Debt-to-Equity | 0.95+0.2x | 0.910.0x | 0.83-0.3x | 0.85-0.2x | 0.74-0.4x | 0.88-0.3x | 1.12-0.3x | 1.06-0.4x |
| Asset Turnover | 0.140.0x | 0.150.0x | 0.140.0x | 0.140.0x | 0.140.0x | 0.160.0x | 0.140.0x | 0.150.0x |
| FCF Margin | 2.2%+0.1pp | 16.1%+0.8pp | 9.4%-4.0pp | 0.2%+3.9pp | 2.1%-3.8pp | 15.2%-3.1pp | 13.4%+1.6pp | -3.8%-0.9pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. GEHC | FY2025 | $20.6B | $2.1B | 10.1% | $29.7B | 55/100 |
| Veeva Systems Inc. VEEV | FY2026 | $3.2B | $908.9M | 28.4% | $47.9B | 68/100 |
| Tempus AI, Inc. TEM | FY2025 | $1.3B | -$245.0M | -19.3% | $12.9B | 40/100 |
| Doximity, Inc. DOCS | FY2026 | $644.9M | $196.1M | 30.4% | $5.4B | 88/100 |
| HealthEquity, Inc HQY | FY2026 | $1.3B | $215.2M | 16.4% | $7.7B | 68/100 |
| Waystar Holding Corp. WAY | FY2025 | $1.1B | $112.1M | 10.2% | $5.1B | 59/100 |
Where GE HealthCare Technologies Inc. Ranks
Frequently Asked Questions
What is GE HealthCare Technologies Inc.'s annual revenue?
GE HealthCare Technologies Inc. (GEHC) reported $20.6B in total revenue for fiscal year 2025. This represents a 4.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is GE HealthCare Technologies Inc.'s revenue growing?
GE HealthCare Technologies Inc. (GEHC) revenue grew by 4.8% year-over-year, from $19.7B to $20.6B in fiscal year 2025.
Is GE HealthCare Technologies Inc. profitable?
Yes, GE HealthCare Technologies Inc. (GEHC) reported a net income of $2.1B in fiscal year 2025, with a net profit margin of 10.1%.
What is GE HealthCare Technologies Inc.'s EBITDA?
GE HealthCare Technologies Inc. (GEHC) had EBITDA of $3.3B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does GE HealthCare Technologies Inc. have?
As of fiscal year 2025, GE HealthCare Technologies Inc. (GEHC) had $4.5B in cash and equivalents against $9.5B in long-term debt.
What is GE HealthCare Technologies Inc.'s gross margin?
GE HealthCare Technologies Inc. (GEHC) had a gross margin of 40.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is GE HealthCare Technologies Inc.'s operating margin?
GE HealthCare Technologies Inc. (GEHC) had an operating margin of 13.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is GE HealthCare Technologies Inc.'s net profit margin?
GE HealthCare Technologies Inc. (GEHC) had a net profit margin of 10.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does GE HealthCare Technologies Inc. pay dividends?
Yes, GE HealthCare Technologies Inc. (GEHC) paid $0.14 per share in dividends during fiscal year 2025.
What is GE HealthCare Technologies Inc.'s return on equity (ROE)?
GE HealthCare Technologies Inc. (GEHC) has a return on equity of 20.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is GE HealthCare Technologies Inc.'s free cash flow?
GE HealthCare Technologies Inc. (GEHC) generated $1.5B in free cash flow during fiscal year 2025. This represents a -3.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is GE HealthCare Technologies Inc.'s operating cash flow?
GE HealthCare Technologies Inc. (GEHC) generated $2.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are GE HealthCare Technologies Inc.'s total assets?
GE HealthCare Technologies Inc. (GEHC) had $36.9B in total assets as of fiscal year 2025, including both current and long-term assets.
What are GE HealthCare Technologies Inc.'s capital expenditures?
GE HealthCare Technologies Inc. (GEHC) invested $482.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does GE HealthCare Technologies Inc. spend on research and development?
GE HealthCare Technologies Inc. (GEHC) invested $1.3B in research and development during fiscal year 2025.
What is GE HealthCare Technologies Inc.'s current ratio?
GE HealthCare Technologies Inc. (GEHC) had a current ratio of 1.37 as of fiscal year 2025, which is considered adequate.
What is GE HealthCare Technologies Inc.'s debt-to-equity ratio?
GE HealthCare Technologies Inc. (GEHC) had a debt-to-equity ratio of 0.91 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is GE HealthCare Technologies Inc.'s return on assets (ROA)?
GE HealthCare Technologies Inc. (GEHC) had a return on assets of 5.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is GE HealthCare Technologies Inc.'s P/E ratio?
GE HealthCare Technologies Inc. (GEHC) trades at 15.6x earnings, its market capitalization divided by net income of $1.9B net income, trailing 12 months to March 31, 2026. The market capitalization is $29.7B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is GE HealthCare Technologies Inc.'s price-to-sales ratio?
GE HealthCare Technologies Inc. (GEHC) trades at 1.4x sales, its market capitalization divided by revenue of $21.0B revenue, trailing 12 months to March 31, 2026. The market capitalization is $29.7B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is GE HealthCare Technologies Inc.'s Altman Z-Score?
GE HealthCare Technologies Inc. (GEHC) has an Altman Z-Score of 1.79, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is GE HealthCare Technologies Inc.'s Piotroski F-Score?
GE HealthCare Technologies Inc. (GEHC) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are GE HealthCare Technologies Inc.'s earnings high quality?
GE HealthCare Technologies Inc. (GEHC) has an earnings quality ratio of 0.95x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can GE HealthCare Technologies Inc. cover its interest payments?
GE HealthCare Technologies Inc. (GEHC) has an interest coverage ratio of 6.28x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is GE HealthCare Technologies Inc.?
GE HealthCare Technologies Inc. (GEHC) scores 55 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.